Immune Globulin Infusion (Human), 10% ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	1

65. 原発性免疫不全症候群

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01485796 (ClinicalTrials.gov)	December 29, 2011	2/12/2011	Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD	Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) ...	Primary Immunodeficiency Diseases (PID)	Biological: Immune Globulin Infusion (Human), 10%;Biological: Recombinant human hyaluronidase	Baxalta now part of Shire	NULL	Completed	2 Years	N/A	All	54	Phase 2/Phase 3	United States

First Previous1Next Last